Integrum (Q2 preview): More than a sprain - Redeye
Redeye adjusts its fair value range following the announcement of the rights issue. We also provide a Q2 2025 preview in light of the expectations communicated by the company.
ANNONS
Redeye adjusts its fair value range following the announcement of the rights issue. We also provide a Q2 2025 preview in light of the expectations communicated by the company.